Predicting survival in patients receiving continuous flow left ventricular assist devices: The Heartmate II risk score

Keyphrases

• 90-day Mortality 16%
• 95% Confidence Interval 100%
• Albumin 16%
• Area under the Receiver Operating Characteristic (AUROC) 16%
• Bridge to Transplantation 16%
• Coagulopathy 16%
• Continuous-flow Left Ventricular Assist Device (CF-LVAD) 100%
• Creatinine 16%
• Destination Therapy 16%
• HeartMate II 100%
• Hypoalbuminemia 16%
• International Normalized Ratio 16%
• Left Ventricular Assist Device 16%
• Left Ventricular Assist Device Support 50%
• Logistic Regression 16%
• Mortality Prediction 16%
• Odds Ratio 83%
• Older Patients 16%
• Operative 16%
• Patient Selection 16%
• Renal Dysfunction 16%
• Risk Prediction Model 16%
• Risk Score 100%
• Selection Strategy 16%
• Survival Prediction 100%
• Thoratec 16%
• Transplantation Therapy 16%
• Validation Cohort 50%

Medicine and Dentistry

• Albumin 20%
• Clinician 20%
• Coagulopathy 20%
• Creatinine 20%
• Hypoalbuminemia 20%
• Left Ventricular Assist Device 100%
• Logistic Regression Analysis 20%
• Odds Ratio 100%
• Patient Selection 20%
• Prediction Model 20%
• Risk Stratification 20%
• Thoratec 20%

Immunology and Microbiology

• Albumin 100%